Market Place
Sourcing Support
Dipeptidyl Peptidase 3 Biomarker to Drive Precision Medicine in COVID-19
11 Apr 2022 //
ACCESSWIRE
Adrenomed receives EMA’s advice for clinical development of Adrecizumab
06 Dec 2021 //
PHARMABIZ
Adrenomed Announces +ve Top-Line AdrenOSS-2 Phase II Results with Adrecizumab
21 Feb 2020 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.